Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.
Clinical trial NCT05249959 · RECRUITING
Trial details
- NCT number
- NCT05249959
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2026-03-21
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.